When was Somnair Sleep founded?

Somnair Sleep was founded in 2024 and raised its 1st funding round 1 year after it was founded.

Where is Somnair Sleep located?

Somnair Sleep is headquartered in Baltimore, United States.

Who is the current CEO of Somnair Sleep?

Anders Sideris and Anders Sideris s of Somnair Sleep. Anders Sideris has also founded 1 company.

How many employees does Somnair Sleep have?

As of Jun 30, 2026, the latest employee count at Somnair Sleep is 5.

Is Somnair Sleep a funded company?

Somnair Sleep is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jun 20, 2025.

When was the latest funding round of Somnair Sleep?

Somnair Sleep's latest funding was a $***** Series A round on Jun 20, 2025, with participation from 0 investor. Its primary sector is Sleep Medicine. In United States, the Sleep Medicine sector has seen $134M in funding in 2026 to date.

Where does Somnair Sleep rank among its competitors?

Somnair Sleep ranks 7th amongst 20 active competitors, of which 5 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Restora Medical, which secured $11.5M in May, 2026.

Who are the top competitors of Somnair Sleep?

Somnair Sleep's top competitors include Nyxoah, Respicardia and XII Medical. Among them, Restora Medical secured the most recent funding round in May, 2026.

Somnair Sleep - 2026 Company Profile, Team, Funding & Competitors

Somnair Sleep is a series A company based in Baltimore (United States), founded in 2024 by Phoebe D, Shri Prabha Shivram, Anders Sideris and Anders Sideris. It operates as a Developer of a non-invasive neurostimulation device for obstructive sleep apnea. Somnair Sleep has raised $4.32M in funding. The company has 20 active competitors, including 5 funded and 2 that have exited. Its top competitors include companies like Nyxoah, Respicardia and XII Medical.

Company Details

Developer of a non-invasive neurostimulation device for obstructive sleep apnea. The device is currently in the pre-clinical development stage. It is on the pathway to clinical studies. Information provided is subject to change as research progresses.

Website: www.somnairsleep.com/
Email ID: *****@somnairsleep.com

Key Metrics

Founded Year

2024

Location

Baltimore, United States

Stage

Series A

Total Funding

$4.32M in 1 round

Latest Funding Round

Series A, Jun 20, 2025, $*****

Ranked

7^th among 20 active competitors

Employee Count

5 as on Jun 30, 2026

Similar Companies

Nyxoah & 22 more

View Somnair Sleep's full profile

Somnair Sleep has raised a total funding of $4.32M over 1 round.

Here is the list of recent funding rounds of Somnair Sleep:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 20, 2025	3997056	Series A	9457628	3903069	6050942	3150292

Access funding benchmarks and valuations. Sign up today!

View details of Somnair Sleep's funding rounds and investors

The founders of Somnair Sleep are Phoebe D, Shri Prabha Shivram, Anders Sideris and Anders Sideris. Anders Sideris and Anders Sideris are the CEOs of Somnair Sleep.

Here are the details of Somnair Sleep's key team members:

Phoebe D: Co-Founder of Somnair Sleep and founder of 1 other company.
Contact Info: 1 email address
Shri Prabha Shivram: Co-Founder of Somnair Sleep.
Contact Info: 1 email address
Anders Sideris: Co-Founder & CEO of Somnair Sleep.
Contact Info: 1 email address
Anders Sideris: Co-Founder & CEO of Somnair Sleep.
Contact Info: 1 email address

View details of Somnair Sleep's Founder profiles and Board Members

Somnair Sleep's employee count trend

Somnair Sleep has 5 employees as of Jun 26. Here is Somnair Sleep's employee count trend over the years:

Uncover Somnair Sleep's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Somnair Sleep include Nyxoah, Respicardia and XII Medical. Here is the list of Top 10 competitors of Somnair Sleep, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nyxoah 2009, Mont Saint Guibert (Belgium), Public	Provider of a neurostimulation device for obstructive sleep apnea treatments	$88.7M	Cochlear, Gilde Healthcare & 8 others	62/100
2nd	Respicardia 2006, Minnetonka (United States), Acquired	Manufacturing implantable stimulation device to improve cardiovascular health by restoring natural breathing at night	$185M	Versant Ventures, Polaris Partners & 9 others	52/100
3rd	XII Medical 2021, United States, Series B	Developer of a device for the treatment of obstructive sleep apnea	$75M	Omega Funds, Broadview Ventures & 9 others	43/100
4th	Siesta Medical 2009, Los Gatos (United States), Seed	Provider of minimally invasive sleep apnea treatment systems. It offers a quick, safe, and lasting treatment to unblock the airway, improving sleep quality without the need for masks or machines. The system is designed for patient comfort and quick recovery, and is adjustable and reversible. The treatment is as effective as more complex surgeries but at a lower cost. The company also provides resources and support materials for both patients and healthcare providers.	$1.93M	-	34/100
5th	M.I. Cloud Tech 2021, Singapore (Singapore), Unfunded	Provider of magnetic interference cloud technology to develop solutions for healthcare, food technology, and green technology industries	-	-	31/100
6th	Restora Medical 2023, Irvine (United States), Series B	Developer of restorative sleep apnea therapy using targeted nerve stimulation	$21M	-	29/100
7th	Somnair Sleep 2024, Baltimore (United States), Series A	Developer of a non-invasive neurostimulation device for obstructive sleep apnea	$4.32M	-	29/100
8th	Brain Electrophysiology Laboratory 1980, Eugene (United States), Funding Raised	Provider of neuroscience technologies for sleep management	-	HHS	28/100
9th	Zeus 2022, United Kingdom, Seed	Developer of a non-invasive anti-snoring device	$199K	British Design Fund	26/100
10th	Neuro Code Research 2015, Singapore, Unfunded	Developer of devices to stimulate sleep	-	-	26/100